Page last updated: 2024-10-24

positive regulation of PERK-mediated unfolded protein response

Definition

Target type: biologicalprocess

Any process that activates or increases the frequency, rate or extent of the PERK-mediated unfolded protein response. [GO_REF:0000058, GOC:bf, GOC:PARL, GOC:TermGenie, PMID:22013210]

The unfolded protein response (UPR) is a cellular stress response activated by the accumulation of unfolded or misfolded proteins in the endoplasmic reticulum (ER). The PERK branch of the UPR is a key pathway involved in attenuating ER stress and restoring homeostasis. Positive regulation of PERK-mediated UPR involves a series of events that enhance PERK activation and downstream signaling.

1. **PERK dimerization and autophosphorylation:** Under normal conditions, PERK exists as an inactive monomer in the ER membrane. Accumulation of misfolded proteins in the ER lumen triggers PERK dimerization and autophosphorylation. This conformational change activates PERK's kinase activity.

2. **eIF2α phosphorylation:** Activated PERK phosphorylates the α subunit of eukaryotic initiation factor 2 (eIF2α). Phosphorylated eIF2α inhibits the translation initiation complex, leading to a global decrease in protein synthesis. This reduction in protein translation alleviates the stress on the ER by reducing the load of newly synthesized proteins.

3. **ATF4 expression:** The eIF2α phosphorylation also leads to increased translation of ATF4, a transcription factor that plays a critical role in the UPR. ATF4 promotes the expression of genes involved in ER stress response, including chaperones, foldases, and proteins involved in ER-associated protein degradation (ERAD).

4. **CHOP expression:** ATF4 also activates the expression of C/EBP homologous protein (CHOP). CHOP is a pro-apoptotic transcription factor that promotes cell death under prolonged ER stress. However, CHOP also contributes to the adaptation response by inducing autophagy, a process that removes misfolded proteins and organelles from the cell.

5. **ER chaperone expression:** ATF4 and other transcription factors activated during the UPR induce the expression of ER chaperones, such as glucose-regulated protein 78 (GRP78) and protein disulfide isomerase (PDI). These chaperones assist in protein folding and prevent aggregation of misfolded proteins.

6. **ERAD activation:** The UPR also activates ERAD, a pathway that removes misfolded proteins from the ER and targets them for degradation by the proteasome.

7. **Feedback regulation:** The UPR is tightly regulated through feedback mechanisms. As ER stress is alleviated and protein homeostasis is restored, the UPR signaling pathway is downregulated. This ensures that the UPR is activated only when necessary and does not disrupt normal cellular function.

8. **Modulation by other signaling pathways:** The PERK-mediated UPR can be influenced by other signaling pathways, such as the mTOR pathway and the MAPK pathway. These pathways can modulate the activity of PERK and the downstream signaling events, fine-tuning the UPR response to specific cellular conditions.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Tyrosine-protein phosphatase non-receptor type 2A tyrosine-protein phosphatase non-receptor type 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P17706]Homo sapiens (human)

Compounds (30)

CompoundDefinitionClassesRoles
5-iodo-2-(oxaloamino)benzoic acidorganoiodine compound
lithocholic acidlithocholate : A bile acid anion that is the conjugate base of lithocholic acid.

lithocholic acid : A monohydroxy-5beta-cholanic acid with a alpha-hydroxy substituent at position 3. It is a bile acid obtained from chenodeoxycholic acid by bacterial action.

Lithocholic Acid: A bile acid formed from chenodeoxycholate by bacterial action, usually conjugated with glycine or taurine. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as cholagogue and choleretic.
bile acid;
C24-steroid;
monohydroxy-5beta-cholanic acid
geroprotector;
human metabolite;
mouse metabolite
glycyrrhetinic acidcyclic terpene ketone;
hydroxy monocarboxylic acid;
pentacyclic triterpenoid
immunomodulator;
plant metabolite
oleanolic acidhydroxy monocarboxylic acid;
pentacyclic triterpenoid
plant metabolite
vanadatesvanadate(3-) : A vanadium oxoanion that is a trianion with formula VO4 in which the vanadium is in the +5 oxidation state and is attached to four oxygen atoms.

Vanadates: Oxyvanadium ions in various states of oxidation. They act primarily as ion transport inhibitors due to their inhibition of Na(+)-, K(+)-, and Ca(+)-ATPase transport systems. They also have insulin-like action, positive inotropic action on cardiac ventricular muscle, and other metabolic effects.
trivalent inorganic anion;
vanadium oxoanion
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor
ursolic acidhydroxy monocarboxylic acid;
pentacyclic triterpenoid
geroprotector;
plant metabolite
madecassic acidmonocarboxylic acid;
pentacyclic triterpenoid;
tetrol
antioxidant;
plant metabolite
maslinic acid(2Alpha,3beta)-2,3-dihydroxyolean-12-en-28-oic acid: from Luehea divaricata and Agrimonia eupatoriadihydroxy monocarboxylic acid;
pentacyclic triterpenoid
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
plant metabolite
geniposideterpene glycoside
asiatic acidmonocarboxylic acid;
pentacyclic triterpenoid;
triol
angiogenesis modulating agent;
metabolite
celastrolmonocarboxylic acid;
pentacyclic triterpenoid
anti-inflammatory drug;
antineoplastic agent;
antioxidant;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
Hsp90 inhibitor;
metabolite
cryptotanshinonecryptotanshinone: from Salvia miltiorrhizaabietane diterpenoidanticoronaviral agent
boswellic acidboswellic acid: ursane type; RN given refers to (3alpha,4beta)-isomer; active principle of salai guggal; see also record for salai guggaltriterpenoid
procurcumenolprocurcumenol: RN given for (1S-(1alpha,3abeta,8aalpha))-isomer; epiprocurcumenol is the (1S-(1alpha,3aalpha,8aalpha))-isomer; a TNF-alpha antagonist isolated from Curcuma zedoaria; structure in first sourcesesquiterpenoid
pinocembrin
genipiniridoid monoterpenoidanti-inflammatory agent;
antioxidant;
apoptosis inhibitor;
cross-linking reagent;
hepatotoxic agent;
uncoupling protein inhibitor
2-(oxaloamino)benzoic acid(oxaloamino)benzoic acid
chlorogenic acidcaffeoylquinic acid: Antiviral Agent; structure in first source

chlorogenate : A monocarboxylic acid anion that is the conjugate base of chlorogenic acid; major species at pH 7.3.
cinnamate ester;
tannin
food component;
plant metabolite
tocopherylquinonetocopherylquinone: RN refers to (3R-(3R*,7R*,11R*))-isomer; structure
illudalic acidilludalic acid: isolated from Clitocybe illudens; structure in first source
eupatoriopicrinegermacranolide
2-amino-6-chloropurine6-chloroguanine : An organochlorine compound that is 7H-purin-2-amine substituted by a chloro group at position 6.

6-chloroguanine: an antimalarial that inhibits hypoxanthine-guanine-xanthine phosphoribosyltransferase; structure in first source
2-aminopurines;
organochlorine compound
corosolic acidtriterpenoidmetabolite
11-keto-boswellic acid
3-epioleanolic acidtriterpenoidmetabolite
oleanonic acidoleanonic acid: structure in first source
zedoarondiolzedoarondiol: structure in first source
formylchromoneformylchromone: structure in first source
rk 682
variabilinvariabilin: an RGD-containing antagonist of glycoprotein IIb-IIIa from the hard tick, Dermacentor variabilis; amino acid sequence given in first source